These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8148002)

  • 41. Inhibitory effect of stearidonic acid (18:4 n-3) on platelet aggregation and arachidonate oxygenation.
    Kockmann V; Spielmann D; Traitler H; Lagarde M
    Lipids; 1989 Dec; 24(12):1004-7. PubMed ID: 2559279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng.
    Lee JG; Lee YY; Kim SY; Pyo JS; Yun-Choi HS; Park JH
    Pharmazie; 2009 Sep; 64(9):602-4. PubMed ID: 19827304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-platelet effects of flavonoids and flavonoid-glycosides from Sophora japonica.
    Kim JM; Yun-Choi HS
    Arch Pharm Res; 2008 Jul; 31(7):886-90. PubMed ID: 18704331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists.
    Hansen TN; Brockbank KG
    Transfusion; 1997 Jul; 37(7):696-702. PubMed ID: 9225932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
    Soslau G; McKenzie RJ; Brodsky I; Devlin TM
    Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between platelet aggregation and dephosphorylation of a 68 kDa protein revealed through the use of putative PKC inhibitors.
    Turini ME; Gaudette DC; Holub BJ; Kirkland JB
    Thromb Haemost; 1993 Oct; 70(4):648-53. PubMed ID: 7509513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 51. Suppression of the voltage-gated K+ current of human megakaryocytes by thrombin and prostacyclin.
    Kapural L; Fein A
    Biochim Biophys Acta; 1997 Mar; 1355(3):331-42. PubMed ID: 9061004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets.
    Nakano T; Hanasaki K; Arita H
    FEBS Lett; 1988 Jul; 234(2):309-12. PubMed ID: 2968921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent antiplatelet effects of cyclic clofibric acid (CPIB) analogs on human platelets.
    Romstedt KJ; Kim SU; Witiak DT; Newman HA; Feller DR
    Thromb Res; 1989 May; 54(4):289-99. PubMed ID: 2503906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentiation of endoperoxide analog-induced platelet aggregation by heparin.
    Mehta P; Mehta J
    Thromb Res; 1982 Jan 1-15; 25(1-2):91-9. PubMed ID: 7064132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
    Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M
    Cell Biochem Funct; 1991 Apr; 9(2):79-85. PubMed ID: 1718622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of leukotriene C4 synthase in human platelets via receptor-mediated mechanisms.
    Edenius C; Tornhamre S; Näsman-Glaser B; Eriksson I; Björkholm S; Lindgren JA
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():333-5. PubMed ID: 7732865
    [No Abstract]   [Full Text] [Related]  

  • 57. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevation of platelet cyclic AMP level by thromboxane A2/prostaglandin H2 receptor agonists.
    Ishikawa Y; Ogawa A
    Thromb Res; 1991 Dec; 64(6):667-76. PubMed ID: 1665927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
    Barradas MA; Jagroop A; O'Donoghue S; Jeremy JY; Mikhailidis DP
    Thromb Res; 1993 Aug; 71(3):227-36. PubMed ID: 8267765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
    Vargaftig B; Joseph D; Hatmi M
    Thromb Res; 1987 May; 46(4):509-17. PubMed ID: 3039684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.